Articles published by The Motley Fool
Exelixis: A Strong Contender in the Cancer Drug Market ↗
March 31, 2026
Via The Motley Fool
Tickers
EXEL
Rivian Stock Is Cheap, but Does That Make It a Buy Now? ↗
March 31, 2026
What I’d Buy Instead of Chasing the Magnificent 7 ↗
March 31, 2026
Why Arm Stock Surged Today ↗
March 31, 2026
Is This the Bottom for Alphabet Stock's Dip in 2026? ↗
March 31, 2026
Six in 10 Investors Own AI Stocks. Should You? ↗
March 31, 2026
Via The Motley Fool
Via The Motley Fool
Tickers
SOFI
2 Dividend Stocks to Hold for the Next 20 Years ↗
March 31, 2026
Via The Motley Fool
Tickers
TSX:ENB
Via The Motley Fool
The Best Canadian Stocks to Buy and Hold Forever in a TFSA ↗
March 31, 2026
Via The Motley Fool
The Top Canadian Stocks to Buy Right Away With $40,000 ↗
March 31, 2026
Via The Motley Fool
Is This Weight Loss Drug Stock a Buy After a New Approval? ↗
March 31, 2026
Via The Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
